フォローフィードコミュニティでトレーダーや投資家とつながりましょう.
包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.
ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Change in Medivir's Board of Directors PR Newswire STOCKHOLM, Oct. 20, 2023 STOCKHOLM, Oct. 20, 2023 /PRNewswire/ -- Medivir AB (Nasdaq: MVIR...
Issue, repurchase and reclassification of shares of series C and transfer of ordinary shares under LTIP 2023 PR Newswire HUDDINGE, Sweden, May...
Execution of the annual general meeting's resolution on the removal of share class in Medivir AB (publ) PR Newswire STOCKHOLM, May 4, 2023...
Resolutions at the Annual General Meeting in Medivir on 4 May 2023 PR Newswire STOCKHOLM, May 4, 2023 STOCKHOLM, May 4, 2023 /PRNewswire/...
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2023 PR Newswire HUDDINGE, Sweden, April 27, 2023 HUDDINGE, Sweden, April 27, 2023 /PRNewswire/...
Medivir presents new data at AACR showing significantly improved antitumor efficacy in non-clinical tumor models with fostrox in triple...
Medivir 2022 Annual Report published PR Newswire STOCKHOLM, April 4, 2023 STOCKHOLM, April 4, 2023 /PRNewswire/ -- Medivir AB (NASDAQ Stockholm:...
Notice of Annual General Meeting of Medivir AB (publ) PR Newswire STOCKHOLM, March 31, 2023 STOCKHOLM, March 31, 2023 /PRNewswire/ -- The...
Medivir to present data on additive efficacy of fostrox in triple combination with anti-PD1 and kinase inhibitor in nonclinical tumor models at...
First patient dosed in the phase 2a part of Medivir's study with fostrox in combination with Lenvima® PR Newswire STOCKHOLM, March 14, 2023...
Medivir to present at the Stockholm Corporate Finance Life Science Day PR Newswire STOCKHOLM, March 8, 2023 STOCKHOLM, March 8, 2023 /PRNewswire/...
Medivir to present at the Erik Penser Bank Healthcare Day PR Newswire STOCKHOLM, Feb. 23, 2023 STOCKHOLM, Feb. 23, 2023 /PRNewswire/ -- Medivir...
Pia Baumann takes up her position as Chief Medical Officer PR Newswire STOCKHOLM, Feb. 21, 2023 STOCKHOLM, Feb. 21, 2023 /PRNewswire/ -- Medivir...
Medivir has determined the recommended phase 2 dose for fostrox in combination with Lenvima in HCC PR Newswire STOCKHOLM, Feb. 20, 2023...
MEDIVIR AB - YEAR-END REPORT JANUARY - DECEMBER 2022 PR Newswire HUDDINGE, Sweden, Feb. 15, 2023 HUDDINGE, Sweden, Feb. 15, 2023 /PRNewswire/...
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約